Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

Jennifer L. Leiting, Matthew C. Hernandez, Lin Yang, John R. Bergquist, Tommy Ivanics, Rondell P. Graham, Mark J. Truty

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences